NEOS Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$29.1M |
| 2 |
Apple
AAPL
|
+$26.2M |
| 3 |
NVIDIA
NVDA
|
+$19.5M |
| 4 |
Amazon
AMZN
|
+$16.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$12.5M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$848K |
| 3 |
Goldman Sachs
GS
|
+$583K |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$523K |
| 5 |
Travelers Companies
TRV
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Healthcare | 14.59% |
| 3 | Communication Services | 10.45% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
VeriSign
VRSN
$26.9B
| – | – |
-996
| Closed | -$205K |
|
|
577
Vanguard Russell 2000 ETF
VTWO
$16.8B
| – | – |
-154,591
| Closed | -$12.5M |
|
578
Warner Music
WMG
$15.2B
| – | – |
-7,917
| Closed | -$283K |
|
579
Wheaton Precious Metals
WPM
$68.1B
| – | – |
-6,363
| Closed | -$314K |
|
|
CBAY
580
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-15,189
| Closed | -$359K |
|
|
SPLK
581
DELISTED
Splunk Inc
SPLK
| – | – |
-5,563
| Closed | -$848K |
|
|
IMGN
582
DELISTED
Immunogen Inc
IMGN
| – | – |
-17,626
| Closed | -$523K |
|
Similar funds
NEOS Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, NEOS Investment Management held 582 positions worth $1.61B, up 53% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
NEOS Investment Management deployed $437M of net new capital in Q1 2024, opening 73 new positions and adding to 454 existing holdings. Its largest new stake was Keros Therapeutics: 14,264 shares worth $944K.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Goldman Sachs, an estimated $583K trimmed.
- NEOS Investment Management's largest Q1 2024 buy was Keros Therapeutics: 14,264 shares worth $944K.
- NEOS Investment Management added most to Microsoft in Q1 2024, an estimated $29.1M increase.
- NEOS Investment Management's biggest Q1 2024 reduction was Goldman Sachs, cutting an estimated $583K.
- NEOS Investment Management fully exited Vanguard Russell 2000 ETF in Q1 2024, selling an estimated $12.5M.
- NEOS Investment Management's ten largest holdings make up 34% of its $1.61B portfolio in Q1 2024.
- NEOS Investment Management opened 73 new positions and closed 16 in Q1 2024.
- NEOS Investment Management's portfolio value rose 53% quarter-over-quarter to $1.61B.
Based on NEOS Investment Management's 13F filing for Q1 2024, filed 13 May 2024.